Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]

Jeroen Vendrik; Floortje van Kesteren; Martijn S. van Mourik; Jan J. Piek; Jan G. Tijssen; Jose P. S. Henriques; Joanna J. Wykrzykowska; Rob J. de Winter; Antoine H. G. Driessen; Abdullah Kaya; M. Marije Vis; Karel T. Koch; Jan Baan

doi:https://doi.org/10.1016/j.amjcard.2018.07.009

Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]

Jeroen Vendrik, Floortje van Kesteren, Martijn S. van Mourik, Jan J. Piek, Jan G. Tijssen, Jose P. S. Henriques, Joanna J. Wykrzykowska, Rob J. de Winter, Antoine H. G. Driessen, Abdullah Kaya, M. Marije Vis, Karel T. Koch, Jan Baan

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2172-2173
Journal	American Journal of Cardiology
Volume	122
Issue number	12
DOIs	https://doi.org/10.1016/j.amjcard.2018.07.009
Publication status	Published - 2018

Access to Document

https://doi.org/10.1016/j.amjcard.2018.07.009

Cite this

Vendrik, J., van Kesteren, F., van Mourik, M. S., Piek, J. J., Tijssen, J. G., Henriques, J. P. S., Wykrzykowska, J. J., de Winter, R. J., Driessen, A. H. G., Kaya, A., Vis, M. M., Koch, K. T., & Baan, J. (2018). Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]. American Journal of Cardiology, 122(12), 2172-2173. https://doi.org/10.1016/j.amjcard.2018.07.009

@article{7217df0d20b240ac906d3c0f09854f7d,

title = "Corrigendum to {\textquoteleft}Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device{\textquoteright} [American Journal of Cardiology (2018) 856-861]",

author = "Jeroen Vendrik and {van Kesteren}, Floortje and {van Mourik}, {Martijn S.} and Piek, {Jan J.} and Tijssen, {Jan G.} and Henriques, {Jose P. S.} and Wykrzykowska, {Joanna J.} and {de Winter}, {Rob J.} and Driessen, {Antoine H. G.} and Abdullah Kaya and Vis, {M. Marije} and Koch, {Karel T.} and Jan Baan",

year = "2018",

doi = "https://doi.org/10.1016/j.amjcard.2018.07.009",

language = "English",

volume = "122",

pages = "2172--2173",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "12",

}

Vendrik, J, van Kesteren, F, van Mourik, MS , Piek, JJ , Tijssen, JG , Henriques, JPS , Wykrzykowska, JJ , de Winter, RJ , Driessen, AHG, Kaya, A, Vis, MM , Koch, KT & Baan, J 2018, 'Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]', American Journal of Cardiology, vol. 122, no. 12, pp. 2172-2173. https://doi.org/10.1016/j.amjcard.2018.07.009

Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]. / Vendrik, Jeroen; van Kesteren, Floortje; van Mourik, Martijn S. et al.
In: American Journal of Cardiology, Vol. 122, No. 12, 2018, p. 2172-2173.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]

AU - Vendrik, Jeroen

AU - van Kesteren, Floortje

AU - van Mourik, Martijn S.

AU - Piek, Jan J.

AU - Tijssen, Jan G.

AU - Henriques, Jose P. S.

AU - Wykrzykowska, Joanna J.

AU - de Winter, Rob J.

AU - Driessen, Antoine H. G.

AU - Kaya, Abdullah

AU - Vis, M. Marije

AU - Koch, Karel T.

AU - Baan, Jan

PY - 2018

Y1 - 2018

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85052308122&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30166047

U2 - https://doi.org/10.1016/j.amjcard.2018.07.009

DO - https://doi.org/10.1016/j.amjcard.2018.07.009

M3 - Article

C2 - 30166047

SN - 0002-9149

VL - 122

SP - 2172

EP - 2173

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 12

ER -

Vendrik J, van Kesteren F, van Mourik MS , Piek JJ , Tijssen JG , Henriques JPS et al. Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]. American Journal of Cardiology. 2018;122(12):2172-2173. doi: https://doi.org/10.1016/j.amjcard.2018.07.009

Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]

Access to Document

Other files and links

Cite this